New Horizon Health Limited (HK:6606) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
New Horizon Health Limited, a biotech firm specializing in cancer screening products in China, reports that its business operations remain stable despite the ongoing suspension of its stock trading. The company continues to work towards resuming trading, following guidance from the Hong Kong Stock Exchange. Investors are advised to stay informed as the company makes further announcements on its progress.
For further insights into HK:6606 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue